May 25, 2022CorporateTerumo Blood and Cell Technologies Inaugurates Second Manufacturing Facility in Colorado
May 17, 2022CorporateTerumo Pharmaceutical Solutions Offers Pre-Fillable Syringe Solutions for Demanding Low Dose Applications Such as Ophthalmic
May 16, 2022CorporateTerumo Announces Change in Indication for Dexcom G6 CGM System in Japan Adjunctive use of Blood Glucose Meter Principally Not Required
Top Management Message Message from top management to shareholders and investors. /investors/management/message Corporate Governance /about/governance Compliance /about/compliance Directors and Executive Officers /about/management Business Risks Major risks that may affect the business performance and financial position of the Terumo Group are described. /investors/management/risk IR Policy /investors/management/ir_policy Disclaimer /investors/disclaimer
